Six-Year Follow-Up of Glucagon-like peptide-1 receptor agonist (GLP1-RA) Therapy in a Patient With Exogenous Insulin Antibody Syndrome: A Case Report

AACE Endocrinology and Diabetes · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles